How to Achieve Efficiency and Consistency in Your 3D Cell Cultures
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
Despite these advantages, widespread adoption has lagged, largely due to lack of standardization, reproducibility challenges, and the perception that 3D culture is too complex or costly.
With the FDA’s recent commitment to phasing out animal testing for drug evaluation, the spotlight is now on in vitro models—and 3D culture is at the forefront.
If you’ve been considering integrating these models into your pipeline, now is the moment to act. Join us at this webinar to learn how you can support the movement toward non-animal testing.
You’ll discover:
- Why cell-based 3D models are a leap forward in predictive power
- How to leverage technology that simplifies and standardizes the development of tissue-specific 3D models
- Real-world data showcasing how novel organoids are driving next-gen discovery